Cons: lower per-capsule dose (175 mg) means you need 2-4 capsules daily, higher cost per effective dose than standard capsules, no Setria certification, sustained-release clinical data is less robust than liposomal data
Other Factors That May Affect Urination During GLP-1 Therapy Several concurrent factors may influence urinary patterns in patients taking GLP-1 medications, and it is important to consider these when evaluating symptoms: Concomitant medications : Many patients on GLP-1 therapy take other medications that affect urination
Antioxidant Defense : It protects cells from oxidative damage by neutralizing free radicals and reactive oxygen species (ROS)
The research in this area is increasing rapidly because of the promising results
GSTP1 is generally not expressed in human hepatocytes (Sison-Young et al., 2015), however, expression is often up-regulated under stress conditions and in tumors (Tew and Townsend, 2012)